Contact
Please use this form to send email to PR contact of this press release:
Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts
TO:
Please use this form to send email to PR contact of this press release:
Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts
TO: